Probe is pleased to announce that it has started clinical evaluations of its MicroEye and ContinuMon monitoring systems. The first evaluation has commenced at St Peter’s Hospital Chertsey UK. Subsequent clinical work will commence in other centres in the New Year.
Neil Smith will be a delegate at the forthcoming ESICM Lives 2017 conference and exhibition in Vienna. For details of the meeting see http://www.esicm.org/events/event/Vienna-2017 Please contact Neil – firstname.lastname@example.org to arrange to meet there.
The latest publication from the Nanodem project shows the progress made in Point of Care (POC) testing systems for use with Probe’s MicroEye sampling system. Please click here for full details
Probe Scientific will be exhibiting at 14th Annual Critical Care Symposium on Thursday 27th and Friday 28th April in Manchester
Medical device company, Probe Scientific, is developing its existing microdialysis technology to provide therapeutic antibiotic drug monitoring for healthcare practitioners at the bedside. They will work with UCL’s Professor Mervyn Singer, Head of the Centre for Intensive Care, and his group of leading experts in sepsis, infection, and blood monitoring; to validate the technology for…
Read more »
Probe will be exhibiting at “ ISICEM” in Brussels from the 20th – 24th March 2017. Neil Smith will be available all week for discussions regarding clinical evaluations, potential research projects and distribution opportunities.
Probe Scientific will be exhibiting at the ISICEM upcoming event in March 2017. To view details of the proposed program CLICK HERE
The NanoDem project is reaching its conclusion with the successful development of a prototype analyser. Partners met in Munich Nov 28 to Dec 1st for the final review meeting which involved assessment by the EC project officer. Clinical evaluations will take place during the summer 2017 on receiving ethics committee approval which is expected any…
Read more »